Abstract:Objectives: Patients with recurrent squamous cell carcinoma of the head and neck (HNSCC) have a poor prognosis and limited therapeutic alternatives. While reirradiation is feasible, it is usually associated with high treatment toxicity and is not yet considered the standard of care. Based on current NCCN guidelines, in the context of very advanced head and neck cancer (recurrent and/or persistent disease), surgical intervention is explored initially with/without adjuvants while unresectable disease is approached with radiation and/or systemic therapies. Specific and reliable prognostic indicators for both -oncologic and functional outcomes- have yet to be defined for this population. Methods: Retrospective chart review of 54 patients treated with reirradiation at a tertiary academic institution between January of 1998 and January of 2024. Only patients with non-metastatic recurrent, and second primary HNSCC were included in the series. Demographics, staging, radiation dose and technique, additional therapy, histopathologic variables, EORTC toxicity, pre- and post-treatment PEG/tracheotomy dependency and oncologic outcomes were retrieved. Results: The study cohort consisted of 54 patients (37 males, 17 females) with HNSCC, averaging 62.7 years in age. Initial tumors were locally advanced in over 42 % of cases, with 58 % being node-negative. The head and cutaneous regions (24.5 %) and tongue (20.8 %) were the most common tumor sites. Primary surgical resection and adjuvant radiation were performed in 47.2 % of cases, and concurrent chemotherapy was used in 40.7 %. Reirradiation was mainly for local or regional recurrence (88.9 %), often following salvage surgery (68.5 %), with a mean dose of 5623 Gy over 52.5 fractions. Positive surgical margins were present in 29.4 % of cases, and extracapsular spread in 59.5 %. No significant differences were found between the salvage surgery and definitive reirradiation groups except for tumor site (P = 0.022). Median follow-up was 52.6 months, with 27 deaths reported. Lymphovascular invasion was significantly correlated with overall survival (P = 0.017), while initial tumor T-stage and neck disease involvement were linked to local-regional control (P = 0.030 and P = 0.033, respectively). Reirradiation increased tracheotomy and PEG-tube dependency by 20 % (P = 0.011) and 23 % (P = 0.003), respectively. Conclusions: Reirradiation is a feasible therapeutic alternative in recurrent head and neck SCC. Oncologic outcomes observed in this series compare favorably to most published reports. Complete response and perineural invasion were independent prognostic factors for survival and locoregional control. While no mortality directly associated with treatment was observed in this series, reirradiation had a significant impact in functional outcomes in terms of increased risk of tracheotomy and peg tube dependency. Further studies are required to define the role of this treatment in head and neck cancer.

Indications and Outcomes of Radiation Therapy for Skin Cancer of the Head and Neck

Advances in Nonsurgical Treatment of Head and Neck Squamous Cell Carcinoma

The role of radiotherapy in the management of non‐melanoma skin cancer

Efficacy of elective nodal irradiation in skin squamous cell carcinoma of the face, ears, and scalp

Neoadjuvant Immunotherapy in Non-melanoma Skin Cancers of the Head and Neck

Soft tissue sarcomas: radiation as a therapeutic option

Organ-sparing radiation therapy for head and neck cancer

Reirradiation of head and neck cancer in the era of intensity-modulated radiotherapy: patient selection, practical aspects, and current evidence

A critical review of the progress in prevention and treatment of radiation-induced skin damage

Reirradiation in head and neck squamous cell carcinoma; prognostic indicators, oncologic and functional outcomes

Prevention and treatment of radiation-induced acute dermatitis in head and neck cancer patients: a systematic review

Grade IV Radiation Skin Injury on the Neck of a Patient with Tonsillar Carcinoma: A Case Report

The role of radiation therapy in the treatment of early-stage skin cancer

The impact of radiation therapy in patients with systemic sclerosis and head and neck cancer

Radiotherapy in the Treatment of Primary or Recurrent Unresectable Desmoid Tumors of the Neck.

Clinical outcomes after post-operative radiotherapy for breast cancer patients presenting with ipsilateral supraclavicular metastasis: considerations on the cranial border of irradiation field

Neurological complications of modern radiotherapy for head and neck cancer

Curative Radiotherapy for Locally Advanced Scalp Squamous Cell Carcinoma

Re-irradiation versus systemic therapy for the management of local-regionally recurrent head and neck cancer

Advancements of radiotherapy for recurrent head and neck cancer in modern era

Non-operative management for oral cavity carcinoma: Definitive radiation therapy as a potential alternative treatment approach